Abstract: There are disclosed methods for producing fermented milk and whey that enable effective production in high yield of fermented milk and whey having high content of an ACEI peptide that is highly safe and applicable to pharmaceuticals, functional foods, health foods, and the like. The methods are: a method including the steps of mixing lactic acid bacteria and a starting material containing milk by stirring to prepare a mixed material, and fermenting the mixed material under stirring so that curd pieces and whey containing an angiotensin converting enzyme inhibitory peptide are generated, whereby fermented milk containing the curd pieces and the whey containing the angiotensin converting enzyme inhibitory peptide is produced; and a method including the steps of subjecting the resulting fermented milk to centrifugation and/or filter pressing to separate and recover whey.

Abstract: There are disclosed methods for producing fermented milk and whey that enable effective production in high yield of fermented milk and whey having high content of an ACEI peptide that is highly safe and applicable to pharmaceuticals, functional foods, health foods, and the like. The methods are: a method including the steps of mixing lactic acid bacteria and a starting material containing milk by stirring to prepare a mixed material, and fermenting the mixed material under stirring so that curd pieces and whey containing an angiotensin converting enzyme inhibitory peptide are generated, whereby fermented milk containing the curd pieces and the whey containing the angiotensin converting enzyme inhibitory peptide is produced; and a method including the steps of subjecting the resulting fermented milk to centrifugation and/or filter pressing to separate and recover whey.

Abstract: There are disclosed methods for producing fermented milk and whey that enable effective production in high yield of fermented milk and whey having high content of an ACEI peptide that is highly safe and applicable to pharmaceuticals, functional foods, health foods, and the like. The methods are: a method including the steps of mixing lactic acid bacteria and a starting material containing milk by stirring to prepare a mixed material, and fermenting the mixed material under stirring so that curd pieces and whey containing an angiotensin converting enzyme inhibitory peptide are generated, whereby fermented milk containing the curd pieces and the whey containing the angiotensin converting enzyme inhibitory peptide is produced; and a method including the steps of subjecting the resulting fermented milk to centrifugation and/or filter pressing to separate and recover whey.

Abstract: A method, apparatus, and article of manufacture for resolving long-busy conditions for synchronized data sets. A long-busy condition is detected in a first one of the synchronized data sets. Further access to the first data set is prevented and all subsequent accesses are directed to another, available, second one of the data sets during the long-busy condition. All updates that are made to the second data set during the long-busy condition are identified and stored in a data structure. An untimed read operation is used to determine when the long-busy condition has cleared. Once the long-busy condition is cleared, the first data set is placed into a recovery mode, wherein the identified updates are applied to the first data set. During the recovery mode, the first data set is read-inhibited to prevent read accesses thereto, but the first data set is write-enabled to allow write access thereto.

Abstract: Granules and tablets for oral administration, containing angiotensin-converting enzyme inhibiting peptides and treated whey with a mixing fluid bed processor, wherein said whey is obtained from lactic acid fermentation liquid. The granules have properties of narrow particle distributions, low moisture absorption, and heavy specific gravity, as well as high free flowing. A process is also provided for producing the granules by the steps of: a) onto seed granules obtained in an earlier operation in a mixing fluid bed processor, spraying purified whey of lactic acid fermentation liquid to form preliminary granules; b) treating the preliminary granules thus obtained to reduce particle size in a size reduction mill; c) returning the treated powder to the mixing fluid bed processor, and, d) spraying additional purified whey onto the returned powder in the mixing fluid bed processor to form granules, while fluidizing the said powder.

Abstract: In a method of purifying whey separated from lactic acid fermentation liquid by electrodialysis wherein said whey contains angiotensin-converting enzyme inhibiting peptides, the improvement which comprises using an anion exchange membrane having a permeability of diffusion coefficient in the range of 3.0 to 9.0×10−6 cm/sec. An anion exchange membrane having a permeability of diffusion coefficient in the range of 5.0 to 7.0×10−6 cm/sec. is more efficiently used. The product is particularly suited to produce granules and tablets.

Abstract: A toner resin composition composed of a vinyl-type copolymer which has styrene-type monomers and (meth)acrylic ester-type monomers as the main ingredients, a low-melting-point crystalline compound, and a block compolymer of polystyrene and polyolefin wherein the average particle area is 0.5-20 &mgr;m2 and the maximum particle area is 30 &mgr;m2 or less in any 25 &mgr;m×25 &mgr;m area when transmission electron microscopy is used to observe said low-melting-point crystalline compound which forms domains in the domain-matrix structure formed by said vinyl-type copolymer and the low-melting-point crystalline compound. To provide a toner resin composition and toner which have superior fixability, anti-offset properties, and shelf stability.

Abstract: A toner resin composition, as well as a toner prepared therefrom, are disclosed which are excellent in fixability, offset resistance and storage stability, and which result in reduced occurrence of DF staining.The toner resin composition includes (a) a vinyl copolymer containing 25 or lower % by weight of molecular species having molecular weights of 200,000 or higher; and (b) 3 to 10% by weight of ethylene-based olefin polymer which has a DSC-determined peak (melting point) within a range of 85-100.degree. C., a weight average molecular weight (Mw) within a range of 500-900, a number average molecular weight (Mn) within a range of 500-900, and a melt viscosity of 10 to 17 cps at 100.degree. C.

Abstract: A toner resin composition and toner is provided, wherein said toner resin composition comprises a high molecular weight resin having a peak molecular weight of about 100,000-4,000,000, or a gel content of about 20% or more is blended with another resin comprising at least a low molecular weight component (having a peak molecular weight of about 3,000-50,000, making up about 60-95 wt % of the resin weight) and a high molecular weight component (having a peak molecular weight of about 100,000-4,000,000, making up about 5-40 wt % of another resin weight).

Abstract: A toner whose main binder is a vinyl-type copolymer which has a styrene-type monomer and/or a (meth)acrylic ester monomer as constituent units wherein the vinyl-type copolymer has peaks of the molecular weight distribution at least in the range from 3.times.10.sup.3 to 4.times.10.sup.4 and in the range from 3.times.10.sup.5 to 8.times.10.sup.6, and the BET specific surface area of the main binder is 0.02-0.2 m.sup.2 /g.

Abstract: A toner resin composition and toner is provided, wherein said toner resin composition comprises a high molecular weight resin having a peak molecular weight of about 100,000-4,000,000, or a gel content of about 20% or more is blended with another resin comprising at least a low molecular weight component (having a peak molecular weight of about 3,000-50,000, making up about 60-95 wt % of the resin weight) and a high molecular weight component (having a peak molecular weight of about 100,000-4,000,000, making up about 5-40 wt % of another resin weight).

Abstract: A toner resin composition is provided which is superior in anti-offset properties, anti-smearing properties and low temperature fixability, has superior image stability even when the copier is used for a long duration of time, and is not prone to aggregation. The toner resin composition mainly comprises a vinyl-type copolymer(s) which contains a low polymer component which is cross-linked using a cross-linking agent comprising diacrylate or dimethacrylate obtained from a diol which has a linear chain with a carbon number of 5 or more with no branches, or a branch(es) with a carbon number of 1 or less and has a peak molecular weight in the molecular weight distribution curve of from about 4.times.10.sup.3 to 8.times.10.sup.4 and a non-cross-linked high polymer component which has a peak molecular weight in the molecular weight distribution curve of from about 1.times.10.sup.5 to 4.times.10.sup.

Abstract: To provide a toner resin composition and toner which has superior anti-offset properties, low temperature fixability and anti-blocking properties, and gives sufficiently stable high-quality images even when copying is done over a long duration of time. This toner resin composition is a toner resin composition comprising a low molecular weight vinyl polymer component and a high molecular weight vinyl polymer component which comprising styrene-type monomers and (meth)acrylic esters as structural units of said polymer components and having peaks of the molecular weight distribution in the region of molecular weights from about 4.times.10.sup.3 to about 8.times.10.sup.4 and in the region of molecular weights from about 1.times.10.sup.5 to about 4.times.10.sup.

Abstract: Disclosed herein is a resin composition for toner mainly composed of a graft polymer which is formed by (a) 90 to 99.9 percent by weight of a copolymer formed by copolymerizing a styrene monomer and (meth)acrylic ester to contain at least 50 percent by weight of the styrene monomer and (b) 0.1 to 10 percent by weight of an ethylene-vinyl acetate copolymer having a saponification value of 10 to 30 and a softening point of 70.degree. to 200.degree. C. This resin composition is prepared by graft-polymerizing the copolymer (a) and the ethylene-vinyl acetate copolymer (b) under presence of a peroxide polymerization initiator. When a polyvalent metal compound (c) is employed, 85 to 99.9 percent by weight of the copolymer (a) and 0.1 to 10 percent by weight of the ethylene-vinyl acetate copolymer (b) are graft-polymerized under presence of 0.01 to 5 percent by weight of the polyvalent metal compound (c) and a peroxide polymerization initiator.